Clinical Trial Update: Memantine as a Supplement to Naltrexone in Treating Heroin Dependence [Phase 2, Phase 3]

View source ↗

Summary

Memantine was studied as a supplement to naltrexone for heroin/opioid dependence. The trial completed Phase 2 and Phase 3 with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heroin Use Disorder
• Opioid Use Disorder

Drugs mentioned

• Memantine (memantine)
• Naltrexone (Naltrexone)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Opioid Dependence, Heroin Dependence | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-07-04